Head-to-head · WeighScore
10rx vs CoreAge Rx
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 66.1/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | 10rx | CoreAge Rx |
|---|---|---|
| WeighScore | 66.1/100 | 89.5/100 |
| Grade | C | B+ |
| Site position | #222 | #1 |
| Semaglutide | $99/mo equivalent, billed $297 quarterly (advertised compounded injection base; confirm pharmacy choice and renewal) | Product page from $79/mo; navigation $99. Confirm selected quote. |
| Tirzepatide | $149/mo equivalent, billed $447 quarterly (advertised compounded injection base; confirm pharmacy choice and renewal) | From $129/mo advertised; confirm selected charge, supply and renewal. |
| Coverage | All-state coverage claimed in company blog; confirm prescribed product, clinician and dispensing eligibility for your state | US only; therapy-specific state restrictions apply |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #222 · C
Strengths
- Publishes quarterly base charges and monthly equivalents for semaglutide and tirzepatide
- Advertises the same medication-specific package price across available strengths
- Advertises consultations, shipping and ongoing support without separate service fees
- Terms identify 10Rx, Inc.; the directory names Wasef Health Physicians and three pharmacy brands
What to consider
- Quarterly pricing is an upfront commitment; exact renewal charge and usable supply remain unverified
- A separate campaign lists a $75 Hallandale charge; applicability and frequency need confirmation
- Fixed-term plans require completion; canceling future renewals does not establish a refund for unused treatment
- Initial cancellation must precede prescribing; refill requests require 48 hours before pharmacy transmission, not necessarily before billing
- Named networks do not establish the treating practice, assigned dispensing branch or individual state eligibility
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.